PRESS RELEASE published on 10/14/2025 at 18:47, 11 months 10 days ago Spineway : Revenue growth in the third quarter Spineway Group reports 18% revenue growth in Q3 2025 driven by Premium ranges and strong performance in Latin America and Asia Revenue Growth Latin America Q3 2025 Premium Ranges Spineway Group
BRIEF published on 07/30/2025 at 19:29, 1 year 1 month ago Spineway: Half-yearly review 2025 and outlook Financial Results Treasury Growth Spineway Spinal Implants
PRESS RELEASE published on 07/30/2025 at 19:24, 1 year 1 month ago Spineway : H1 2025 results - Continued improvement in results and financial position Spineway reports improved H1 2025 results with net loss narrowing by €2 million. Revenue target for 2025 confirmed. Solid cash position of €4 million as of June 30, 2025 Revenue Growth Financial Performance Cash Position Spineway H1 2025 Results
BRIEF published on 06/06/2025 at 18:37, 1 year 3 months ago Spineway General Meeting Results PEA-PME Turnover General Assembly Resolutions Approved Spineway
PRESS RELEASE published on 06/06/2025 at 18:32, 1 year 3 months ago Spineway : Minutes of the General Meeting of June 4, 2025 Spineway shareholders approve multiple resolutions at General Meeting. Company eligible for PEA-SME. Details on website General Meeting Resolutions PEA-SME Exports Spineway
BRIEF published on 03/21/2025 at 08:50, 1 year 6 months ago Spineway legal proceedings against Strategos: new decision Arbitration Spineway Strategos Delaware Sentence
BRIEF published on 02/27/2025 at 18:35, 1 year 6 months ago Spineway stands out at Arab Health 2025 Middle East Distribution Spineway Arab Health 2025 Spinal Implants
BRIEF published on 12/04/2024 at 20:05, 1 year 9 months ago Spineway reduces its share capital by reducing the nominal value of the shares Actions Capital Reduction Sotck Exchange Nominal Value Spineway
PRESS RELEASE published on 12/04/2024 at 20:00, 1 year 9 months ago Spineway carries out a capital reduction by reducing the par value of its shares Spineway reduces share capital through a par value decrease to facilitate conversions and protect from compensation mechanisms. No impact on market value or outstanding shares Share Capital Reduction Spineway Par Value Decrease Compensation Mechanism Capital Reduction Impact
Published on 09/25/2026 at 07:30, 4 hours 24 minutes ago Tocvan Reports Positive Closed-Circuit Column Leach Results at Gran Pilar
Published on 09/25/2026 at 00:30, 11 hours 24 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 11 hours 39 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 13 hours 53 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/25/2026 at 10:00, 1 hour 54 minutes ago AI and supply chains open new pathways to systemic stress as risks become more interconnected, find Swiss Re Institute and LSE
Published on 09/25/2026 at 09:09, 2 hours 44 minutes ago flatexDEGIRO sets course for next phase of growth
Published on 09/25/2026 at 09:08, 2 hours 46 minutes ago EQS-Adhoc: flatexDEGIRO expands Management Board
Published on 09/24/2026 at 18:00, 17 hours 54 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 17 hours 54 minutes ago GUILLEMOT CORPORATION: 2026 CONSOLIDATED INTERIM RESULTS
Published on 09/24/2026 at 17:45, 18 hours 9 minutes ago Cegedim first-half 2026 results: profitability continues to improve
